ES2494618T3

Cardiac valve prosthesis

Abstract

Cardiac replacement valve for use within a human body comprising: a valve component (100); and a stent component (800), the stent and valve components having a folded configuration with the folded valve component (100) housed within the stent stent component (800) for placement of both components at the site of placement at the same time, and an expanded configuration after implantation, the stent component (800) being self-expanding to the expanded configuration, the stent component (800) comprising a first section (802), a second section (804) for housing the valve component, and a third section (806) , wherein the first section (802) comprises an annular groove, characterized in that the second section (804) has a shape that follows an outline of the valve component.

ES2494618T3, drawing sheet 1 — Sheet 1 of 32

Term

0.2 yearsto projected expiry

Projected expiry 22 December 2026, counted from filing; an application has no term until it is granted.

5 claims: 2 independent, 3 dependent

1
E11153142 E11153142 20-08-2014 20-08-2014 CLAIMS REIVINDICACIONES 1. Cardiac replacement valve for use within a human body comprising:a valve component (100);and a stent component (800), 1. Válvula cardiaca de sustitución para su uso dentro de un cuerpo humano que comprende: un componente (100) de válvula;y un componente (800) de endoprótesis, 5 The stent and valve components may have a folded configuration with the folded valve component (100) housed within the folded stent component (800) for placement of both components at the placement site at the same time, and an expanded configuration after implantation, 5 pudiendo tener los componentes de endoprótesis y de válvula una configuración plegada con el componente (100) de válvula plegado alojado dentro del componente (800) de endoprótesis plegado para la colocación de ambos componentes en el sitio de colocación al mismo tiempo, y una configuración expandida tras la implantación, siendo el componente (800) de endoprótesis autoexpansible hasta la configuración expandida, comprendiendo el componente (800) de endoprótesis una primera sección (802), una segunda sección (804) para the stent component (800) being self-expanding to the expanded configuration, the stent component (800) comprising a first section (802), a second section (804) for 10 housing the valve component, and a third section (806), in which the first section (802) comprises an annular groove, characterized in that the second section (804) has a shape that follows an outline of the valve component. 10 alojar el componente de válvula, y una tercera sección (806), en la que la primera sección (802) comprende una hendidura anular, caracterizada porque la segunda sección (804) tiene una forma que sigue un contorno del componente de válvula.
5
Válvula de sustitución según la reivindicación 4, en la que la segunda sección comprende una pluralidad de 20 elementos (828) de bloqueo que sobresalen hacia fuera desde la superficie exterior de la segunda zona y en la que al menos dos de la pluralidad de elementos de bloqueo están colocados en posiciones diferentes a lo largo de un eje central del componente de endoprótesis. 6. Apparatus comprising:a replacement valve according to any one of the preceding claims, and 25 a cover (2206) to maintain the stent component and the valve component in the folded configuration, the cover being able to be removed to allow the stent component and the valve component to be reconfigured in the expanded configuration. 20

Independent claims2

311 paragraphs in 17 sections, as filed

E11153142

20-08-2014

DESCRIPTION

Heart valve prosthesis

Field of the Invention

Embodiments of the present invention relate to stent valves and associated methods and systems for placement through minimally invasive surgery, and closure devices compatible with guide wires for plugging access holes.

Background of the invention

Conventional approaches to cardiac valve replacement require the cutting of a relatively large opening in the sternum ("sternotomy") or in the thoracic cavity ("thoracotomy") of the patient to allow the surgeon to access the patient's heart. In addition, these approaches require the patient's heart to stop and a cardiopulmonary shunt (that is, the use of a heart-lung shunt machine to oxygenate and circulate the patient's blood). Despite their invasiveness, these surgical approaches can be reasonably safe for a first intervention. However, tissue adhesions resulting from the first surgery may increase the risks (eg death) associated with subsequent valve replacement surgeries. See Akins et al., "Risk of Reoperative Valve Replacement for Failed Mitral and Aortic Bioprostheses", Ann Thorac Surg 1998; 65: 1545-52; and Weerasinghe et al., "First Redo Heart Valve Replacement A 10-Year analysis", Circulation 1999, 99: 655-658.

US 2004/0106976 discloses a replacement valve with a valve component and a stent component having an annular groove.

Synthetic valves and biological valves have been used for cardiac valve replacement with variable results. Synthetic valves rarely fail but require lifelong anticoagulant therapy to prevent blood clotting (thrombosis) in and around the replacement valve. Such anticoagulant treatment significantly limits the activities of patients and can cause various other complications. Biological valves do not require an anticoagulant treatment of this type but usually fail within 10-15 years. Therefore, to limit the need for and the risks associated with a new operation in defective biological valves, traditionally only patients with a life expectancy of less than 10-15 years have received biological valve substitutions. Patients with a longer life expectancy have received synthetic valves and anticoagulant treatment.

Attempts have been made to develop less invasive surgical procedures for cardiac valve replacement. These surgical procedures, called percutaneous coronary valve replacement therapies (PHVT), use a catheter to place a replacement valve at an implantation site using the patient's vascular system. These attempts at PHVT have various deficiencies, including their inability to ensure proper placement and stability of the replacement valve within the patient's body.

Conventional closure devices for closing access holes also have shortcomings in several aspects, including the clearance of their adjustment that can cause bleeding after surgery. These closing devices also lack a central light, which makes them incompatible with the guide wire placement systems. One such conventional closure device is described in Malgorzata Pawelec-Wojtalik, "Closure of left ventricle perforation with the use of muscular VSD occluder", European Journal of Cardio-Thoracic Surgery 27 (2005) 714-716.

In view of the foregoing, it would be desirable to provide improved methods, systems and devices for cardiac valve replacement.

Summary of the invention

Some embodiments of the present invention relate to systems, methods and devices for cardiac valve replacement. For example, these methods, systems and devices may be applicable to the entire range of cardiac valve therapies, including replacement of defective aortic, mitral, tricuspid and pulmonary valves. In some embodiments, the present invention may facilitate a surgical approach whereby surgery is performed on a beating heart without the need for an open heart operation or a heart-lung shunt. This minimally invasive surgical approach can reduce the risks associated with the replacement of a defective native valve in the first case, as well as the risks associated with secondary or subsequent surgeries to replace defective artificial valves (for example, biological or synthetic).

60 E11153142

20-08-2014

The stent valves according to the present invention include a valve component and at least one stent component as described in claim 1. The valve component may include a biological or synthetic (for example, mechanical) valve and / or any Other suitable material. The stent component includes a first section (for example, proximal section), a second section configured to accommodate the valve component, and a third section (for example, distal section). The stent and valve components can adopt at least two configurations: a folded configuration (for example, during placement) and an expanded configuration (for example, after implantation).

In some embodiments, the first section of the stent valve may include a fastener. Such a fastener may include, for example, the annular groove to hold the stent valve in place at an implantation site. When the stent valve includes a single stent (single stent valve), the annular groove may be configured to receive the valve ring that needs to be replaced. When the stent valve includes two stents (double stent valve), the annular groove of the first stent component may be configured for a coupling attachable to a complementary annular shoulder of a second stent component (i.e., a stent) . In turn, the second stent component can be anchored at the implantation site, for example, to the valve that needs to be replaced and / or to the adjacent structures.

Alternatively or additionally, in some embodiments the third section of the stent component may include at least one joint element. Each joint element of the stent valve may include, for example, a geometric opening (for example, circular or oval), a hook, or a tape configured for removable attachment to a complementary structure of a positioning device. In addition, each connecting element can correspond to all or a part of a commissure support, to which a commissure can be attached between the two valve leaflets. The joint member (s) may allow the stent valve to partially expand within a patient's body while the stent valve remains attached to the positioning device. This may allow the stent valve to be returned to a folded configuration and repositioned within the patient's body when it is determined that the full expansion of the stent valve would cause the stent valve to be installed incorrectly. Alternatively or additionally, this may allow the stent valve to be returned to the folded configuration and removed from the patient's body when it is determined that the stent valve does not function properly (for example, it does not allow sufficient flow) . In some embodiments, the stent valve may include a joint element. In other embodiments, the stent valve may include at least two, three, six, or any other suitable number of joint elements. In some embodiments, the diameter of the fully expanded stent in the area of the joint / element may be smaller than the diameter of the area that houses an associated valve. This can reduce the risk of injury to the patient's body (for example, perforation of the aorta) by the joint elements and / or make it easier to fix the joint elements to the complementary structure of the positioning device.

In some embodiments, the stent component of the stent valve may include a reticular structure with a plurality of cells. The reticular structure may be formed, for example, of a shape memory alloy such as nitinol or any other suitable material. The cells in the reticular structure may be densely populated in the section of the stent component that includes the fixation element. This can provide added support to the fixation element and increase the stability of the stent valve. In some embodiments, the reticular structure may form at least one elongated rod (for example, a commissure support) that extends distally along the stent component towards the at least one joint element. The at least one rod can be connected directly to at least one connecting element. Alternatively, the reticular structure may form at least one support element for connecting the at least one rod to at least one connecting element. In some embodiments, all cells in the reticular structure may be closed cells, which may facilitate the new capture of the stent valve from the partially expanded configuration to the folded configuration.

Examples to understand the invention refer to a method for replacing a valve. A stent valve is provided that includes a stent component with an annular groove, and the stent valve is axially attached to a valve ring that needs replacing. In some examples, providing a stent valve may include suturing a valve component to the stent component. Alternatively or additionally, providing a stent valve may include expanding a valve component within the stent component to form a friction fit. In some examples, providing a stent valve may include attaching a valve component to the stent component with a hook and loop fixation system (eg, VELCRO®).

In other examples of the present invention, there is provided a method for replacing a valve, whereby a first stent component that includes an annular element is implanted so that at least a part of the first stent component is housed within a valve It needs replacing. A stent valve that includes a second stent component is placed within the first stent component by attaching a complementary annular member of the second stent component.

fifty E11153142

20-08-2014

stent to the annular element of the first stent component.

According to the present invention, a stent valve placement system is provided as described in claim 6. In some embodiments, a first assembly is provided that includes an outer shell and a guide wire tube. The positioning system also includes a second set that includes a stent carrier configured for its removable attachment to at least one joint element of a stent valve. The stent valve can be placed on the guide wire of the first set. The first set and the second set can be configured for relative movement with respect to each other to move from a closed position to an open position. In the closed position, the outer shell may surround the stent valve still attached to the stent holder and therefore limit the expansion of the stent valve. In the open position, the outer shell may not limit the expansion of the stent valve and, therefore, the stent valve can be separated from the stent holder and expanded to a fully expanded configuration.

In some embodiments, the first set and the second set may be configured to move from the closed position, to a partially open position, to the open position. In the partially open position, the stent valve can be partially expanded but not separated from the stent holder because the outer shell can still surround the at least one joint element of the stent valve and the stent holder. When the stent valve is in the partially expanded configuration, it can be determined whether the stent valve will be positioned correctly if the stent valve expands to the fully expanded configuration. Alternatively or additionally, the functionality of the stent valve can be checked (for example, to determine if the stent valve will allow sufficient blood flow) when the stent valve is in the partially expanded configuration.

In some embodiments, the stent valve placement system may include at least one balloon (for example, proximal to the stent valve or other stent to be placed) configured to cause stent valve expansion or placement of the stent. stent after inflating the at least one balloon.

In some embodiments, the stent valve placement system may include a push handle that causes relative movement of the first set and the second set. Alternatively, the stent valve placement system may include a screw mechanism to transform the rotational movement of a handle into the relative movement of the first set and the second set.

In some embodiments, the stent valve placement system may include an integrated introducer within which the first assembly and the second assembly are located during placement of the stent valve at an implantation site. The integrated introducer may be configured to remain within a patient's body even after the first set and the second set have been removed, for example, to allow the introduction of an occluder.

In some embodiments, after expansion of the stent valve to the fully expanded configuration, the positioning system may be configured to return to the closed position by passing the second assembly through the stent valve toward a distal end of the first set.

Examples to understand the present invention relate to a method of placing a stent valve in an implantation site whereby the stent valve is removably attached to a positioning device and the stent valve is placed in the site. of implantation in a folded configuration. The stent valve can be partially expanded while the stent valve remains attached to the positioning device. A determination can be made regarding the stent valve when the stent valve is in the partially expanded configuration. When the determination produces a positive response, the stent valve can expand to its fully expanded configuration causing the stent valve to separate from the positioning device.

In a particular example, it can be determined whether the stent valve is correctly placed at the implantation site. The stent valve can be returned to the folded configuration and can be repositioned when the stent valve is not positioned correctly at the implantation site.

Alternatively or additionally, it can be determined whether a valve component of the stent valve is functioning properly, for example, by checking whether the valve component will allow sufficient blood flow. The stent valve can be returned to the folded configuration and removed from a patient's body when the stent valve does not work properly.

In some examples, placement of the stent valve at the implantation site may include placing the stent valve in the heart for replacement of a heart valve. Placement may include accessing a patient's body through an intercostal space (for example, the fifth intercostal space) and

Four. Five E11153142

20-08-2014

penetrate the left ventricle at the apex of the heart.

In still other examples, an occluder is provided to seal a hole in the tissue. The occluder may include a first part that can be expanded from a folded configuration on a luminal side of the hole to an expanded configuration. The occluder also includes a second part that can be expanded from a folded configuration to an expanded configuration on one side of the hole opposite the luminal side. The first part and the second part can form a central hollow channel to accommodate a guide wire.

In some examples, the occluder may include a connector to connect the occluder to a catheter. For example, the connector may include a hollow screw mechanism to connect to a threaded catheter. The occluder can be accommodated through a second catheter for placement in the tissue hole.

In some examples, the upper part of the occluder may include a channel sealing mechanism to prevent blood flow from the luminal side of the tissue hole. For example, the channel sealing mechanism may include a membrane, foam and / or a valve. Suitable examples of foam and / or membrane materials include polyurethane and gelatin.

In some examples, the upper part of the occluder may include a first material and the lower part of the occluder may include a second material, where the second material may be thicker than the first material. This can facilitate the formation of scar tissue on the outside and accelerate the healing process. For example, the first and / or second materials may include felt (s) and / or velvet (s) composed of Teflon, Dacron, polyurethane, polydioxanone, polyhydroxybutyrate and / or other material.

In other examples, a method is provided to seal a tissue hole through which an expandable and foldable occlusion device is connected to a first catheter. The occlusion device can be inserted into a second catheter in a folded state. The first catheter and a central channel of the occlusion device can accommodate a guide wire. The second catheter can be placed in the hole, so that a first end of the second catheter is placed on a luminal side of the hole. The relative movement between the folded occlusion device and the second catheter may occur in order to move the occlusion device out of the second catheter. Once the occlusion device emerges from the first end of the second catheter, a first part of the occlusion device can be expanded on the luminous side of the hole. Once the occlusion device has completely emerged from the second catheter, a second part of the occlusion device can be expanded.

Brief description of the drawings

For a better understanding of the present invention reference is made to the following description, taken together with the accompanying drawings, in which the similar reference characters refer to similar parts throughout the document, and in which:

Figure 1A shows a valve component in an expanded configuration according to some embodiments of the present invention;

Figure 1B shows a valve component in a folded configuration according to some embodiments of the present invention;

Figure 2A shows a stent component in an expanded configuration according to some embodiments of the present invention;

Figure 2B shows a single stent valve, which includes a stent component and a valve component, in an expanded configuration according to some embodiments of the present invention;

Figure 2C shows a single stent valve in a folded configuration according to some embodiments of the present invention;

Figure 3A shows a stent component in an expanded configuration according to some embodiments of the present invention;

Figure 3B shows a stent component in a folded configuration according to some embodiments of the present invention;

Figure 4 shows a double stent valve, which includes two stent components and a valve component, in an expanded configuration according to some embodiments of the present invention;

E11153142

20-08-2014

Figures 5A-7B illustrate the use of a single stent valve to replace a defective (artificial) biological valve according to some embodiments of the present invention;

Figures 8A and 8B show a stent component that includes joint elements for fastening the stent to a positioning device and fasteners for fastening the stent at the implantation site according to some embodiments of the present invention;

Figure 8C shows a stent component having a diameter in the area of the joint element (s) that is smaller than the diameter of a stent area that houses an associated valve, according to some embodiments of the present invention;

Figure 8D shows a stent component that includes (one) element / elements that can be folded independently for use in stent placement / restraint with respect to geometry / topology at an implantation site according to some embodiments of the present invention;

Figure 8E shows a stent component that includes locking elements in a crown configuration and a fixing element for securing the stent in an implantation site according to some embodiments of the present invention;

Figure 8F shows a stent component that includes multiple braces to bring a valve component closer to an area of the stent component that includes (a) joint element / elements for attaching the stent component to a positioning device;

Figures 9A-16 show further embodiments of the stent components that include joint elements for fastening the stent to a positioning device and / or fasteners for fastening the stent at the implantation site according to the present invention;

Figures 17/18, 19 and 20 show additional examples of double stent valves according to some embodiments of the present invention;

Figure 21A shows a stent valve in the form of an opposite double crown according to some embodiments of the present invention;

Figures 21B-E show views of a double conical stent according to some embodiments of the present invention;

Figures 22A-22D show a positioning system for placing a self-expanding stent valve in an implantation site according to some embodiments of the present invention;

Figures 23A-23D show a placement system with (one) inflatable balloon / balls according to some embodiments of the present invention;

Figures 24A-24D show a positioning system having a proximal outer axis with a larger diameter according to some embodiments of the present invention;

Figures 25A-25C show a placement system with (one) inflatable balloon / balls according to some embodiments of the present invention;

Figures 26A-26C show a positioning system with an integrated introducer according to some embodiments of the present invention;

Figure 27 is a flow chart of illustrative steps involved in replacing a defective artificial or native valve according to some examples of the present invention; and

Figures 28A-C illustrate the replacement of a defective valve by the use of a positioning system according to some embodiments of the present invention;

Figures 29A and 29B show an occluder compatible with guide wire for sealing an access hole according to some examples;

Figure 30 shows a guide wire to guide the placement of an occluder and / or stent valve according to some examples;

E11153142

20-08-2014

Figure 31 shows a threaded catheter for attachment to and use in the placement of an occluder according to some examples,

Figures 32A and 32B show a positioning system for an occluder according to some examples; and

Figures 33A and 33B show an occluder positioned within an access hole according to some examples of the present invention.

Detailed description of the invention

Figures 1A-3B show components 100, 200 and 300 for use in replacing, for example, an aortic valve, a mitral valve, or a defective (for example, degenerate) pulmonary heart valve (for example, in a patient pediatric) according to some embodiments of the present invention. More particularly, Figures 1A and 1B show a valve component 100. Figures 2A-2C show a stent component 200 for housing a valve component 100. Figures 3A and 3B show a stent component 300 for housing a stent component 200 and a valve component 100. A device that includes components 100 and 200 can be referred to as a single stent valve. A device that additionally includes component 300 may be referred to as a double stent valve.

Figure 4 shows a double stent valve 400 which includes a component a valve component 100, a stent component 200, and a stent component 300 according to some embodiments of the present invention. The double stent valve 400 may replace a defective artificial or native valve. As used herein, a "native valve" refers to a valve naturally present in a patient's body. A defective native valve can be, for example, a stenotic valve. An "artificial valve" refers to a biological or synthetic (for example, mechanical) valve introduced into the patient's body by surgery. Typically, the implantation site for a device 400 (or other replacement valve) includes at least a portion of the area within the defective valve and / or along at least a portion of the adjacent structure (s) . For example, to replace a defective aortic valve, the device 400 may be implanted within the patient's body, so that part 402 of the device is placed substantially completely within the defective aortic valve. The part 404 of the device 400 may extend along at least a part of the aorta. The part 406 of the device may extend into at least a part of the left ventricle of the patient's heart.

The double stent valve 400 may be placed at the implantation site using any suitable placement approach. In some embodiments of the present invention, device 400 may be assembled substantially completely from components 100, 200, and 300 outside the patient's body before device 400 is placed at the implantation site. In other embodiments of the present invention, components 100, 200 and 300 of device 400 may be placed at the implantation site separately in multiple stages. For example, the stent component 300 may be placed and installed at the implantation site, followed by the placement and installation of the stent component 200 and the valve component 100 in one or more separate stages. In one embodiment, components 100 and 200 can be assembled outside the patient's body and then placed and installed within component 300 at the same time. In another embodiment, the stent component 200 may be placed and installed within the stent component 300, followed by the placement and installation of the valve component 100 in a separate stage. Additional embodiments of double stent valves in connection with Figures 17-20 are described.

In some embodiments of the present invention, a single stent valve (Figure 2B) may be used that includes the valve component 100 and the stent component 200 (but not the stent component 300) to replace a defective artificial or native valve . For example, in a particular embodiment, the valve of a single stent may replace a defective biological valve introduced into the body of a patient during a previous valve replacement surgery. Therefore, the surgery involving the valve of a single stent shown in Figure 2B may be a secondary or subsequent valve replacement surgery. Although in this embodiment no new stent component 300 can be introduced into the patient's body, the valve of a single stent that includes components 100 and 200 can be housed in a stent and / or a valve that remains at the site of implantation of previous valve replacement surgery. In some embodiments, at least a portion of the stent and / or the valve of the previous surgery may be removed before the valve of a single stent is installed at the implantation site. Additional details about replacing a defective biological valve with a single stent valve in connection with Figures 5A-7B are described.

In some embodiments of the present invention, the valve component 100 may be flexible and foldable, so that it can be folded, for example, during placement through a catheter at the implantation site. Various embodiments of placement systems and surgical approaches for minimally invasive surgery in connection with Figures 22A-26C are described below. After placement, the valve component can expand at least partially. Figure 1A is a perspective view of a valve component 100 in

60 E11153142

20-08-2014

An expanded configuration. Figure 1B is a perspective view of the valve component 100 in a folded configuration. As used herein, "folded configuration" and "expanded configuration" refer to a relative difference, for example, of the diameter and / or any other physical characteristic of a component (eg, length, width). For example, the folded valve component shown in Figure 1B has a reduced diameter and may or may not be longer than the expanded valve component shown in Figure 1A.

The valve component 100 may include a biological material (for example, hardened, non-hardened, heterologous or autologous), a non-biological material, a synthetic material (for example, one or more polymers such as polyurethane and / or silicone or silicones) , or a combination thereof. In some embodiments, the valve component 100 may include conserved biological tissue such as, for example, human tissue (for example, homografts, autografts of valvular tissue) or animal tissue (heterograft or xenograft of valvular tissue). In some embodiments, the valve component 100 may be a mechanical valve. For example, when the valve component 100 is a biological valve, the expansion of the valve component 100 from a folded to an expanded configuration may require self-expansion of a fixed stent component 200. Instead, a synthetic valve component 100 may be capable of self-expansion. The valve component 100 may have a conformation / shape (for example, length, width, diameter, etc.) corresponding to that of the intended valve application (for example, tricuspid, pulmonary, mitral or aortic). In Figures 1A and 1B, the valve component 100 is a tricuspid valve with three flaps. This particular configuration may be particularly suitable, for example, to replace a defective aortic valve. In other embodiments, the valve component 100 may have any other suitable number of flaps and / or other physical characteristics (eg, diameter, length, width, etc.).

Figure 2A is a perspective view of the stent component 200 according to an embodiment of the present invention. As shown in Figure 2B, the stent component 200 houses the valve component 100. In some embodiments, at least a portion of the stent component 200 may have a substantially cylindrical shape. Alternatively or additionally, the stent component 200 may have a notch (for example, an annular groove) or other fixation element 202, for example, to fix the stent in place at the implantation site. For example, when the stent component 200 forms part of the double stent valve 400 (FIG. 4), the fixation element 202 can be coupled together to a complementary fixation element 302 (for example, an inward annular projection, Figure 3A) of the stent component 300. When the stent component 200 is part of a single stent valve (Figure 2B), the fixing element 202 can be fixed to at least a part of the defective valve. Additional embodiments of the stent components that may include fasteners in connection with Figures 6A and 8A-16 are described.

In the present invention, the stent component 200, such as the valve component 100, can adopt at least two configurations: a first folded configuration (for example, during placement) and a second expanded configuration (for example, after installation ). Figure 2A shows the stent component 200 in an illustrative expanded configuration. Figure 2C shows the stent component 200 in an illustrative folded configuration, with the folded valve component 100 housed therein, for placing both components at the implantation site at the same time. In some embodiments, the stent component 200 can be made of wire or can be laser cut from a tube, a cover, or the like. The stent component 200 may include a shape memory alloy material such as, for example, nitinol. The shape memory alloy may allow compression of the stent component 200 (and / or the valve component 100) to the first configuration, for example, for placement through a small opening in the patient's body and expansion of stent component 200 to the second configuration during installation. Components 100 and / or 200 can be kept in the folded configuration, for example, with a cover or a wrap. The cover / wrap may be removed to allow components 100 and / or 200 to be reconfigured to the second configuration.

The valve component 100 may be attached to the stent component 200 by means of any clamping mechanism or combination of suitable clamping mechanisms. For example, in one embodiment, the valve component 100 may be sutured with one or more stitches to the stent component 200. In another embodiment, the valve component 100 may be attached to the stent component 200 by means of friction adjustment. For example, the valve component 100 may have a fully expanded diameter that is slightly larger than the expanded diameter of the stent component 200, so that the components 100 and 200 fit firmly together after the expansion of the component 100 within the component

200. In yet another embodiment, a hook-and-loop fastening system (eg VELCRO®) can be used to attach the valve component 100 to the stent component 200. For example, the stent component 200 may include microscopic hooks and the valve component 100 may include corresponding microscopic loops (or vice versa). This hook and loop fastening system may include a micropane material, which has been previously used for surgical applications to improve tissue growth. A hook and loop fastening system can allow precise adjustment of the position of the valve component 100 with respect to the position of the stent component 200, for example, after the

55 E11153142

20-08-2014

Components 100 and 200 have been implanted in a patient's body. The hooks / loops can also facilitate blood coagulation and the formation of a seal on the contact surface between the valve component 100 and the stent component 200. To prevent premature clot formation (for example, excessive clot formation before the installation is complete), monitoring and / or anticoagulation treatment can be provided to the patient. Reliable hook and loop connections can continue to be achieved in the presence of premature clot formation, although greater activation pressure (described below) may be required. A preliminary evaluation shows that reliable hook and loop connections can be formed in the presence of water, gel, liquid soap and / or coagulating proteins. In some embodiments, such a hook and loop fastening system, alternatively or additionally, can be used to attach the stent component 200 to the stent component 300 (for example, with the microscopic hooks attached to an outer surface of the component 200 of stents and the corresponding microscopic loops attached to an inner surface of the stent component 300, or vice versa).

Any suitable mechanism or combination of mechanisms (for example, a direct or indirect mechanical compression effort) can be used to supply the activation pressure required to cause the micro-hooks to join the microbucles. For example, in some embodiments, one or more balloons may be placed adjacent to the valve component 100 and / or the stent component 200 (for example, within the valve component 100) and may be temporarily inflated to bring the micro-hooks into contact with the microbucles This / these balloons can be placed within the valve component 100 and / or the stent component 200 after placement of the stent and / or the valve at the implantation site. Alternatively, in some embodiments, the balloon / balloons may / may be mounted (for example, removably mounted) within the valve component 100 and / or the stent component 200 prior to the placement of the stent and / or of the valve at an implantation site (for example, before loading the stent and / or the valve into a placement device). The use of such a balloon or such balloons is not limited to embodiments in which the valve and stent are fixed to each other by means of hooks / loops. Rather, such a balloon or such balloons can / n be used whenever it is necessary or desirable to use the balloon / balls to aid in the expansion and / or coupling at the implant site of the stent and / or the valve ( for example, when the valve is sutured to the stent). In some embodiments, a self-expanding valve component 100 can be provided that self-expands within the stent component 200 to make the micro-hooks make contact with the microbucles.

Figure 3A is a perspective view of the stent component 300 according to an embodiment of the present invention. As described above, the stent component 300 may have a fixation element 302 (eg, an annular projection inwardly) that attaches attachable to a complementary fastener element 202 of the stent component 200 (Figure 2A) . Figure 4 shows an embodiment of such a coupling joint, in which component 300 houses both components 100 and 200 to form the double stent valve 400. The geometry (for example, the length, width (s), diameter (s), etc.) of the stent component 300 may be particularly adapted, for example, for a replacement of aortic valve. In other embodiments, other geometries and configurations of the stent component 300 may be provided.

The stent component 300 may be held in place at the implantation site using any clamping mechanism or combination of suitable clamping mechanisms. For example, in some embodiments, the fixing element 302 may form a recess (for example, an outer annular groove) to receive at least a portion of the defective valve. In some embodiments, the stent component 300 may have a diameter slightly larger than a diameter of the implantation site, so that the placement and expansion of the stent component 300 at the implantation site holds the stent component 300 in place. by means of a friction adjustment. In some embodiments, the stent component 300 may include one or more protrusions (eg, spikes) or clamps to anchor the stent component 300 to the defective valve and / or to the adjacent structure (s) at the implantation site .

Figures 5A-7B illustrate embodiments of the present invention for replacing a defective artificial (for example, biological) stent valve introduced into a patient's body during a previous surgery. Figure 5A is a perspective view of a defective biological valve 500 in which the valves 502 of the valve do not close. Figure 5B is a perspective view of the defective biological valve 500 after implantation of the stent valve shown in Figure 2B. As shown, the defective biological valve 500 (for example, and / or its accompanying stent) holds the new stent valve in place at the implantation site. More particularly, the stent valve fastener 202 (Figures 2A and 2B), which may be an annular groove forming the narrowest part of the stent valve, can receive the defective biological valve ring 500, holding thereby the stent valve in place. In other embodiments of the present invention, at least a portion of the defective biological valve 500 may be removed from the body (for example, the defective valve itself) of the patient, while another or other part (s) of the defective valve may be left in the implantation site (for example, a stent). In still other embodiments, the defective biological valve 500, including all its associated components, can be substantially removed from the implantation site before

60 E11153142

20-08-2014

installation of the new stent valve.

Figure 6A is a perspective view of another example of a stent valve 600 according to an embodiment of the present invention. Figure 6B is a perspective view showing a use of the stent valve 600 to replace a defective artificial (eg biological) valve. The stent valve 600 includes one or more (for example, three) blocking or retention elements 602 along an outer surface of the stent component. Each blocking element 602 may include directionality, so that it is folded (for example, placed flush with an outer surface of the stent component) after coupling of the blocking element with another surface (for example, the inside of a catheter ). When a blocking element 602 protrudes from the outer surface of the stent component, a first end 604 of the blocking element may be adjacent to the outer surface of the stent component, while a second end 606 of the blocking component may be separated from the outer surface of the stent component. When multiple locking elements 602 are provided, the first ends 604 of all blocking elements can be placed substantially at the same vertical height / position along the central axis of the stent component (although dispersed, for example, evenly around of the perimeter of the stent component), and the second ends 606 can be placed at different vertical height (s) / position (positions) than the first ends 604. The first end 604 can be flexible (for example, allowing a movement similar to a two-dimensional joint), so that the movement of the second end with respect to the outer surface of the stent component does not affect the locking mechanism.

In some embodiments of the present invention, the stent valve 600 may be inserted into the defective valve in the direction of arrow 608 in Figure 6B. When the first end 604 of each blocking element 602 meets the inner diameter / ring of the defective valve, the second end 606 of the blocking element can be folded towards the outer surface of the stent component. After reaching the second end 606 of the blocking element an open area of the defective valve, the second end can protrude outward, locking the stent valve 600 in place. Thus, the blocking elements 602 can provide a mechanism for holding the new stent valve in place, as an alternative to or in addition to the fixing element 610 (for example, an annular groove) of the stent component for fixing the valve 600 from stent to (for example) the defective valve ring.

Figures 7A and 7B show another embodiment of a stent component 700 with locking elements according to the present invention. Figure 7A shows that such a stent component may be made, for example, of a sheet of suitable material (for example, nitinol). Referring to Figure 7B, the stent component 700 includes one or more locking elements 702 that extend radially from an outer surface of the stent component so that, for each locking element, the first end 704 and the second end 706 of that locking element have substantially the same vertical position / height along the central axis of the stent component. In other embodiments, such blocking elements may be slightly inclined, so that the ends 704 and 706 of the same blocking element have different relative vertical positions / heights along the central axis of the stent component. In some embodiments, a stent component may be provided that includes multiple locking elements, each locking element having ends 704 and 706 with different angular orientations. Different locking elements 702 may have the same or different vertical positions / heights along the central axis of the stent component.

Figures 8A-16 show additional examples of stent components suitable for use in the replacement of a valve according to some embodiments of the present invention. These stent components can be used, for example, as part of single stent valves and double stent valves. Each of these stent components includes one or more joining elements for removably attaching the stent component (for example, together with an integrated valve component) to a positioning device (Figures 22-26). In some embodiments, these stent components may also include a fixation element (eg, similar to fixation element 202 (Figure 2A)) to fix the stent component in place at the implantation site.

Figure 8A shows a perspective view of a stent component 800 in a folded configuration, as well as a sectional view of the stent component 800 illustrating details about its structure. Figure 8B shows the stent component 800 in an expanded configuration. The stent component 800 includes a first section 802 (for example, proximal) that includes a fixing element (for example, an annular groove), a second section 804 that can follow the contour of a valve component to be housed in the same, and a third section 806 (for example, distal) that includes one or more (for example, three) joining elements 808. In some embodiments, the stent component 800 may include (for example) a reticular structure (for example, formed from nitinol wire), for example, section 802 having a denser population of reticular cells than section 804 and / or section 806. This may provide added support to the fastener in section 802 and, therefore, increase the stability of the device 800 at the implantation site. In some embodiments, the stent component 800 may include only

60 E11153142

20-08-2014

Closed reticular cells to facilitate the new capture of the stent component 800 by means of a positioning device when the stent component 800 is in a partially expanded configuration (described below).

In some embodiments, each of the connecting elements 808 may include an opening (for example, circular or oval) for removably attaching the stent component 800 to a complementary element (for example, a thread, a tape or a hook ) of a placement device. The connecting elements 808 may allow partial expansion of the stent component (for example, together with an integrated valve component and / or another stent component) within a patient's body while causing the stent component to remain attached to the placement system For example, sections 802 and 804 (for example, and part of section 806) of the stent component 800 may expand when the stent component 800 is partially released from an axis during placement, while no change in the relative positions of the connecting elements 808 still limited by the shaft (for example, see figure 28 "partial release"). This may allow a surgeon to reposition and / or check the functionality of the stent valve (or double stent valve) inside the patient's body before completing the deployment of the stent valve at the implantation site. Such checking of the functionality of the valve may include a peripheral pulse monitoring, so that a pulse wave can be measured if the valve is functioning properly. A more reliable evaluation of the function of the stent valve can be carried out with a transesophageal echocardiography (TEE), intravascular ultrasound (IVUS) and / or an intracardiac echocardiography (ICE). If the stent valve is malfunctioning during the test (for example, if the valve does not allow sufficient blood flow), the stent valve can be captured again by means of the positioning device and can be recovered from the patient's body. In other embodiments, the stent component 800 may have a different lattice structure, the length and / or other dimensions of the attachment elements 808 may be reduced or increased, and / or the attachment elements 808 may be included in other locations with respect to the stent component 800 (for example, within section 804).

Figure 8C shows another embodiment of a stent component with integrated joint elements 814 that are configured such that the fully expanded diameter in the area of the joint element (s) is smaller than the diameter of the area that houses an associated valve. . As shown in this example, the connecting elements partially protrude inward towards the central axis of the stent component. This can reduce the risk of injury to the patient's body (for example, perforation of the aorta) by the junction elements. Alternatively or additionally, this may make it easier to fix the connecting elements to a complementary structure of the positioning device. For example, when the device is folded for attachment to the positioning device, the reduced diameter within the area of the joining elements can cause the joining elements to be coupled before the stent holder.

Figure 8D shows yet another embodiment of a stent component according to the present invention. In this embodiment, the first (proximal) section of the stent includes 27 elements 816 that can be folded, independent, each of which may include one or more connected and / or disconnected cells that can be opened and / or closed. In this embodiment, each element that can be folded includes a single closed cell. In other embodiments, another number and / or other configuration of the elements that can be folded can be provided. The elements 816 that can be folded allow precise placement / clamping of the proximal stent section with respect to the geometry / topology of (for example) a calcified ring / defective biological valve. Each element 816 can be folded / adapted independently to the topology of the immediately adjacent part of the calcified ring / defective biological valve. The elements 816 that can be folded together form an annular groove in which the location of the deformation when bending (split part) for each element that can be folded is controlled by reducing or lengthening the lengths of a joined pair of braces (818, 820) of stents that act as a joint. The length of a single stent strap is shown by number 822. Mainly, the radial force / resistance of each element 816 that can be bent is influenced by the selection of angle 824 during stent fabrication. Other design parameters such as the thickness / width of the straps also influence the radial force. An advantage of this design is that the proximal stent section can more adequately anchor the stent in place at the implantation site regardless of the middle section of the stent. Therefore, the middle section of the stent may be designed to house (for example) the aortic valve without any oversizing, thereby reducing the risk of valve failure due to long-term mechanical stress. The stent of Figure 8D also includes a compensation element 826 (for example, which includes a triangular wave portion and two elongated arms) to house a mismatch of elongation (if any) within the stent during manufacturing and / or The crimp. Compare Figure 8D with the embodiment shown in Figure 8C, in which the absence of dedicated pairs of braces prevents the proximal stent section from having elements that bend independently (for example, during implantation).

Figure 8E shows another embodiment of a stent component according to the present invention. In Figure 8E, only approximately 1/3 of a sectional view of the stent component is shown to more clearly show its characteristics. Similar to the locking / retention elements 602 shown in the figures

55 E11153142

20-08-2014

6A and 6B, the stent component shown in Figure 8E includes a plurality of locking elements 828 that can be bent independently, generally located in the area of the stent component called zone 804 in Figure 8B. The blocking elements 828 form a crown that can be coupled, for example, to a defective biological valve or to a calcified native ring from the outlet side. The stent component in Figure 8E also includes the fixation element 830 (for example, an annular groove). In Figure 8E, the blocking elements 828 are shown as being placed substantially in the same position / height along the central axis of the stent component. In other embodiments, different locking elements 828 may have the same or different vertical positions / heights along the central axis of the stent component similarly, for example, to the stent shown in Figure 7B. Having different positions / heights for at least some of the blocking elements 828 can facilitate coupling with, for example, native valves of different sizes (for example, a thin native valve that can be coupled by means of separate blocking elements a small distance or a thick native valve that can only be coupled by means of more separate blocking elements).

Figure 8F shows another embodiment of a stent component according to the present invention. In Fig. 8F, only approximately 1/3 of a sectional view of the stent component is shown to more clearly show its characteristics. Figure 8F includes a Dacron bag 832 for housing a valve component, the Dacron bag 832 being sutured along the valve-free edge 834. As shown, the valve component within the bag 832 is housed closer to the connection element (s) 836, which are similar to the connection elements 808 of Figure 8B, in the embodiment of Figure 8F than in the embodiment shown in Figure 9C. An intermediate U-shaped shoulder strap 838 slides into the Dacron bag 832. The valve / bag is sutured to an outer U-shaped shoulder strap 840 inverted. The inner U-shaped shoulder strap 842 is placed outside the Dacron bag 832 and serves as a slide during loading / releasing / re-capturing the implant with a positioning device reducing frictional forces between the Dacron bag 832 and the external cover. The inner U-shaped shoulder strap 842 can also be sutured to the Dacron bag 832. In some embodiments, the Dacron bag 832 may be closed with additional 844 points. Although the lower part of the stent is not shown in Figure 8F, in some embodiments it may include, for example, a fixing element (eg, annular groove) similar to the fixing element 802 in Figure 8B.

Figures 9A-9C show another example of a stent component 900 with one or more integrated connecting elements 902 according to an embodiment of the present invention. Figure 9A shows a perspective view of the stent component 900 in a folded configuration, as well as a sectional view of the stent component 900 illustrating details about its structure. Figure 9B is a perspective view of the stent component 900 in an expanded configuration. Figure 9C shows the stent component 900 (with an integrated valve component) placed next to a ruler to show its size (for example, approximately 4 centimeters). As shown, each of the connecting elements 902 includes a circular or oval opening connected to the stent component 900 by means of two support elements 904 (for example, threads). In turn, each pair of support elements 904 is attached to a rod 906 (for example, a commissure support) within the reticular structure. Instead, each of the connecting elements 808 in Figure 8B is attached to the stent component 800 by means of a single support element 810, and each support element 810 is attached to a stem 812. All stent components shown in Figures 8A-16 include three stems, although it will be understood that other suitable numbers of stems or no stems can be provided at all (eg, Figure 2A) according to some embodiments of the present invention. The stent component 900 also includes a fixation element 908, which can be substantially similar to the fixation element 202 (Figure 2A). In the embodiment of Figure 9C, the valve component is sutured around the circumference of its ring. Each of the three leaflets of the valve component is also sutured with stitches to the stent to allow the functionality of the valve. Suture locations can be selected to allow stent lengthening during crimping without damaging the valve or suture. For example, the stent entry (for example, in the area 802 shown in Figure 8B) can be covered on its inner side with a cloth (for example, a mesh). The fabric and the valve component may be sutured to the stent (for example, using a continuous and / or interrupted technique) in the area adjacent to the annular groove (for example, along the edge of sections 802 and 804 of the stent in figure 8B). Part of the excess fabric may be folded at the inlet side on the outer side of the stent and sutured together with the valve component in the vicinity (eg, more toward section 804) of the anterior suture location. The corners of the valve component can also be attached to the corresponding stent brackets, which may have been previously covered with cloth (for example, Dacron). Alternatively, pericardium or other suitable material may be used to cover the stent component. In some embodiments, the valve component may be a swine valve component that may have been obtained as such or assembled from various donors to have an optimal correspondence between the three cusps. Bovine and equine valves that are made of pericardium can also be used. Other suitable sources of valve components can also be used.

Figures 10A-10B show yet another example of a stent component 1000 with one or more integrated connecting elements 1002 according to an embodiment of the present invention. Figure 10A shows a perspective view of the stent component 1000 in a folded configuration, as well as a sectional view of the stent.

E11153142

20-08-2014

1000 stent component that illustrates details about its structure. Figure 10B is a perspective view of the stent component 1000 in an expanded configuration. As shown, at least one pair (for example, all pairs) of joining elements 1002 are joined together with a reinforcing element 1004. Each reinforcing element 1004 can be attached at one end to a first connecting element 1002 and at the other end to a second connecting element 1002. In some embodiments, the reinforcement element (s) 1004 may include a wire shaped similar to a triangular wave. When all the connecting elements 1002 include a reinforcing element 1004, the reinforcing elements 1004 may together form a circle around the perimeter of the stent component 1000. The stent component 1000 may be substantially the same as the stent component 800 (Figure 8B) in all other aspects.

Figures 11-16 show additional examples of stent components with one or more integrated joining elements according to some embodiments of the present invention. Each of Figures 11-16 includes a perspective view of a stent component in a folded configuration, as well as a sectional view of the stent component illustrating details about its structure. The following description summarizes various features of the stent components shown in Figures 11-16. From the drawings for one skilled in the art, additional structural features of the embodiments shown in Figures 8A-16 will be apparent.

Figure 11 shows a stent component that includes one or more shorter support elements for attachment to a corresponding number of one or more oval / circular joint elements (ie, shorter compared to the support elements 810). Figure 8B). The stem (s) of Figure 11 for attachment to the support elements may be substantially equal to the stems 906 of Figure 9B.

Figure 12 shows a stent component that includes two support elements for attachment to each oval / circular joint element. Each pair of support elements is attached to a rod, so that, together, the support elements and the rod form a second oval / circular opening, for example, for added support and / or for use as an element of additional or alternative union. The stem (s) in Figure 12 may be substantially the same as the stems 906 in Figure 9B.

Figure 13 shows a stent component that includes non-circular / oval joint components such as, for example, threads, hooks, tapes, or a combination thereof for attachment in a way that can be coupled to a complementary element of a positioning device. (for example, a circular or oval opening). The stent component of Figure 13 also includes a greater number of joint elements (for example, six) compared to the number of joint elements (for example, three) of the stent component 900 (Figures 9A and 9B). In Fig. 13, the connecting elements are attached directly to the stems of the stent component, two connecting elements per rod. The stem (s) of Figure 13 may be substantially the same as the stems 906 of Figure 9B.

Figure 14 shows a stent component that replaces the thread / hook joint elements of Figure 13 with narrow elongated openings (eg elongated and narrow compared to the joint elements 902 of Figure 9A). The stem (s) of Figure 14 may be substantially the same as the stems 906 of Figure 9B.

Figure 15 shows a stent component with a modified reticular structure, including a modified stem structure. The stent component of Fig. 15 also includes circular / oval connecting elements, each connecting element being fixed to a stem by means of two support elements. Each pair of support elements and corresponding rod may form a second circular / oval opening, in a manner similar to the configuration of support element / rod shown in Figure 12.

Figure 16 shows a stent component with modified joint elements with respect to the joint elements shown in Figure 15. Each joint element in Figure 16 includes a thread (eg, a "U" shaped wire) , joining both ends of the wire directly to the same rod, so that the connecting element / rod configuration forms a substantially oval / circular opening. The stem (s) of Figure 16 may be substantially equal to the stems shown in Figure 15.

Figures 17/18, 19 and 20 show additional examples of double stent valves according to some embodiments of the present invention. The valve 1700 of a single stent of Figure 17 includes a stent 1702 and a valve component 1704. Figure 18 shows a double stent valve that includes a stent valve 1700 and a stent 1802, which can be joined together by means (for example) of an annular groove and a corresponding annular recess. The stent component 1802 can be covered, for example, with pericardium to avoid a paravalvular loss. The double stent valve of Figure 18 may have a generally cylindrical shape that is suitable, for example, for pulmonary and / or aortic applications.

55 E11153142

20-08-2014

Referring now to Figures 19 and 20, Figure 19 shows a double stent valve with a first stent 1902, a second stent 1904, and a valve component 1906. Figure 20 shows a double stent valve with a first stent 2002, a second stent 2004, and a valve component 2006. Again, the stents of Figures 19 and 20 may be covered (for example, with pericardium) to avoid a paravalvular loss. The stents of Figures 19 and 20 may be suitable, for example, for a pulmonary valve replacement (for example, in the presence of an aneurysm that creates a deformation and when there is no suitable flange for the placement of a split stent valve ). More particularly, with respect to pulmonary valve applications, many pulmonary valve replacement candidates have an aneurysm therein or a funnel-like configuration at the entrance or exit. Therefore, the first stent 1902 or 2002 can be adapted to this funnel-like pulmonary artery configuration and provide the round hole to hold the stent valve (1904, 1906) or (2004, 2006). In some embodiments, a double stent valve similar to the double stent valve of Figure 20 may be provided that is suitable for mitral and / or tricuspid valve applications, when the stent has a reduced height and an oval configuration that provides a round flange for attachment to a cleft of a stent valve (alternatively, a hook-loop fastening system can be used). Alternatively or additionally, the stent may have elements that can be folded independently that provide a firm fit at the implantation site. From the drawings, additional structural features of the embodiments shown in Figures 17-20 and details about their use for valve replacement will be apparent to one skilled in the art.

Figure 21A shows another example of a stent valve 2100 according to some embodiments of the present invention. The embodiment shown in Figure 21A may be suitable, for example, for a mitral valve replacement. The stent valve 2100 can be assembled from a stent component and a valve component outside the patient's body before the stent valve 2100 is placed in an implantation site. The stent valve 2100 may be a self-expanding stent valve adapted for replacement of the mitral valve. As shown, the stent valve 2100 may have a shape similar to an opposite double crown. The stent valve 2100 may include a porcine pulmonary valve 2102 sutured in a Dacron conduit (prosthetic tube), with two self-expanding nitinol stents 2104 and 2106 in the outer surface of the prosthesis so that two crowns are created self-expanding The self-expanding stent valve can be loaded for placement in a Teflon cover, or other suitable placement system. In this embodiment, Dacron is used to cover the stent, although other materials such as Teflon, silicone, pericardium, etc. may be used in other embodiments. In a surgical approach, a 1 centimeter incision can be made in the left atrium, controlled by a tobacco bag suture. The Teflon shell with a loaded stent can be pushed along a guide wire (having pierced the atrium with a needle and having inserted the guide wire) until the middle part of the stent valve reaches the mitral ring. The cover can then be removed to first deploy the ventricular side, followed by a complete removal of the cover to expose the atrial side. In Liang Ma et al., "Double-crowned valved stents for off-pump mitral valve replacement", European Journal of Cardio-Thoracic Surgery 28: 194-199, June 13, 2005, which is incorporated by reference in its entirety This document describes additional details about the stent valve 2100 and a surgical approach for placement at an implantation site.

Figures 21B-E show views of a double conical stent according to some embodiments of the present invention. With reference to Figures 21B and 21C, the double conical stent may include a substantially cylindrical stent 2108 bearing a valve 2110 as well as two substantially conical stents (2112, 2114) attached / fixed to the stent 2108 (for example, with VELCRO® , one or more sutures, one or more friction adjustments, other suitable joining mechanisms, or a combination thereof). Figure 21D shows a cross section of the double conical stent shown in Figures 21B and 21C. In other embodiments, at least one of stents 2112 and 2114 may have a crown shape with protruding spikes formed from open or closed cells or Z stents. The first and second additional stents (2112, 2114) may together form a fixing element 2116 (Figure 21C; for example, an annular groove) similar to the fixing element 202 shown in Figure 2A. The fixing element 2116 can allow the fixing, for example, in a hole of a defective valve having a size similar to the stent 2108 carrying a valve component 2110 or an anchoring stent with a complementary annular projection. In some embodiments, stents 2112 and 2114 (and optionally stents 2108) can be replaced by a single stent in a double conical configuration (for example, the two cones connected by a continuous area in the area of the fixing element 2116). An advantage of using one or more separate stents for the cones / fixing element is that the mechanical stresses of the cones / fixing element (for example, the first and second stents 2112 and 2114) can be separated at least partially from the stent 2108 which contains the valve. In some embodiments, at least the additional stent or a portion thereof placed closer to the tip of the placement system (for example, stent 2112) can be captured again by means of the positioning system. To facilitate this new capture, the additional stent can be formed with a 2118 cross-sectional pyramid or wing configuration (Figure 21E). In some embodiments, the wing (s) of the stent 2112 (and / or 2114) may be formed at various positions / heights along a central axis of the stent 2108 similarly, for example, to the

60 E11153142

20-08-2014

stent shown in figure 7B. Having different positions / heights for at least some of the wings or spikes can facilitate coupling, for example, with native valves of different sizes. In some embodiments, the stents shown in Figures 21B-21E (for example, stent 2108) may include at least one joint member for removable attachment to a positioning device, similar to the joint members 808 shown in Figure 8B

Figures 22A-26C show examples of placement systems for placing stent valves (for example, single stent valves or double stent valves) at an implantation site according to some embodiments of the present invention. In some embodiments, the present invention provides a minimally invasive surgical approach whereby surgery is performed on a beating heart, without the need for an open heart operation or a heart-lung shunt. The heart can be penetrated, for example, transapically through a relatively small opening in the patient's body. For example, to replace a defective aortic valve, it can penetrate the patient's body through an intercostal space (for example, fifth intercostal space), which is an area between two ribs. From this access point, it can penetrate the left ventricle at the apex of the heart. In one approach, a suitable stent valve placement system may initially penetrate the body / heart (for example, the placement system 2600 (Figures 26A-26C) that includes an integrated introducer). In another approach, a separate introducer cover can be used. A guide wire (a hollow needle, a catheter, a rigid guide wire, etc.) can be inserted through the introducer to guide the placement, for example, of the stent component (s), a valve component, and / or other devices (for example, an occluder device). In some embodiments, transluminal, transauricular or transventricular approaches may be used, for example, for a tricuspid and / or mitral valve replacement. The right ventricle of the heart can also be accessed for a replacement of the pulmonary valve. This contrasts with other surgical approaches that place replacement valves through open heart operations. In addition, as described in more detail below in connection with Figures 22A-28C, the positioning systems according to some embodiments of the present invention first release the proximal part of the stent valve, which may allow the verification of the valve when accessing the body, for example, transparietally. After a satisfactory check, the distal part of the stent valve can be released. This contrasts with the stent placement systems that initially release the distal parts of their associated stents.

Figures 22A-22D show a placement system 2200 that includes two concentrically arranged parts, a first set (which includes elements 2202-2210) and a second set (which includes elements 2216-2230). More particularly, the first assembly may include the tip 2202 at the distal end of the positioning system (passing a guide wire through the length of the positioning system and out the tip), an internal shaft 2204, an outer cover 2206 , a metal shaft 2208, and a push handle 2210. The second assembly may include an outer shaft (distal) 2216, an outer shaft connector 2218 of decreasing section, an outer shaft 2220 (proximal), a stent holder 2222, a strain relief 2224, a clamp handle connector 2226 , a cavity 2228 of clamping handle, and an O-ring 2230. As shown, the push handle 2210 is located at the proximal end of the positioning system. In Figures 22A and 22B, the outer shaft 2220 has been divided along its length to allow the components of the positioning system 2200 to be shown in more detail. The valve 2212 and the stent (s) 2214 form a third set that, for example, can be loaded and crimped between the first and second assemblies.

With respect to the first set, the internal shaft 2204 functions as a light for a guide wire. Tip 2202 joins at its distal end. As used herein, the joint refers to any suitable clamping / fixing mechanism such as, for example, an adhesive bond using cyanoacrylate or UV radiation curing adhesives or heat bonding / welding using thermal energy to melt the components to be assembled. The outer cover 2206 can be attached to the proximal section of the tip 2202 and can limit the stent valve (2212, 2214). The outer cover 2206 can be perforated to allow the device to be washed through the handle 2210. The proximal part of the first assembly can be reinforced with a metal shaft 2208 and can end inside the push handle with a luer connector for a light wash of the guide wire.

With respect to the second set, the stent holder 2222 can be distally attached to the distal outer shaft 2216. Figure 22D shows a perspective view that best illustrates the arrangement between the stent valve (2212, 2214) and the stent holder 2222. The distal outer shaft 2216 can be attached proximally to the proximal outer shaft 2220 by means of the decreasing section connector 2218. The proximal outer shaft 2220 can be attached by means of the deformation guard 2224 to the clamp handle assembly, which may include the clamp handle connector 2226 and the clamp handle cavity 2228. The clamp handle assembly may comprise an O-ring 2230 to seal the placement system 2200. A luer connector can allow the device to be washed. The washing mechanism can be used to remove trapped air from the placement system before insertion into the body. Alternatively or additionally, the washing mechanism can be used to cool a stent (eg, a nitinol stent) before its release and / or new capture by washing the stent with a cold saline solution. Cooling of the stent can cause a reversible modification of its structure, thereby reducing its Young's modulus and, as a result

60 E11153142

20-08-2014

both, the radial force of the stent and the forces necessary for its placement and new capture.

The positioning system 2200 is considered to be in an open position (Figure 22C) when (for example) the pushing handle 2210 comes into contact with the holding handle cavity 2228. In the open position, the stent valve (2212, 2214) can be separated from the stent holder 2222 and fully expanded at an implantation site. Before the placement system 2200 reaches the open position, the stent valve can be crimped into the placement system 2200 by means of a crimping machine (for example) and held in place by the stent holder 2222. The stent holder 2222 can be attached to the stent attachment elements shown in Figures 8A-16. The crimped stent valve can be maintained in a folded configuration by removing the first assembly, thereby covering the joint components / stent holder 2222 with the outer shell 2206. Once the outer cover 2206 has been removed, so that it no longer limits the joint components, the stent valve can be automatically separated from the stent holder 2222 due to the self-expanding property of the stent valve. The positioning system 2200 is considered to be in a closed position (Figures 22A and 22B) when the outer cover 2206 completely surrounds the stent valve (2212, 2214) so that no expansion of the stent valve occurs.

The positioning system 2200 is considered to be in a partially open position when (for example), the push handle 2210 is partially pushed into the holding handle cavity 2228. In this partially open position, the stent valve (2212, 2214) is deployed proximally and remains distally attached to the stent holder 2222 by means of the connecting elements. This allows precise implantation / placement of the stent valve. For example, the stent valve can be partially released proximally with respect to the intended implantation site and pushed slightly distally until resistance is felt. The final release of the stent valve (2212, 2214) can occur by pushing the push handle fully into the holding handle cavity 2228, so that the positioning system 2200 reaches the open position. Figure 28B illustrates such partially open position. In some embodiments, an imaging mechanism can be used to determine if the stent valve is correctly positioned at the implantation site. For example, an arterial cartography can be performed under fluoroscopy with angiography, intravascular ultrasound (IVUS), intracardiac echocardiography (ICE), transesophageal echocardiography (TEE) or other mechanisms or combination thereof, imaging mechanism that can be at least partially solidarity to or independent of the placement system.

After implantation of the stent valve (2212, 2214), the positioning system 2200 can return to the closed position before its recovery from the patient's body, for example, by holding the first set and pushing the second set distally towards the tip 2202 / cover 2206 outside. In other embodiments, the handle for releasing the stent valve may comprise a screw mechanism for transferring a rotational movement of the handle to a translational movement of the outer shell. This type of release system may allow for a more precise and progressive release and re-capture of the stent, as well as a reduction in the release force felt by the surgeon.

Figures 23A-23D show another example of a placement system 2300 according to an embodiment of the present invention. The placement system 2300 may be substantially similar to the placement system 2200 (Figure 22) (for example, the closed position, Figures 23A and 23B; the open position, Figure 23C), except that the placement system 2300 may additionally include one or more folded 2302 balloons (for example, proximal to the stent valve). Unless otherwise indicated, similar characteristics in Figures 23A-23D correspond to the same reference numbers in Figures 22A-22D, although reference numbers have not been reproduced in Figures 23A-23D to avoid complicate the drawings The same applies to the stent placement systems shown in Figures 24A-D, Figures 25A-C and Figures 26A-C. Balloon 2302 can be inflated / deflated by means of an additional light on the proximal outer shaft 2304, for example, to anchor the stent valve (for example, a non-self-expanding stent valve) in place at an implantation site. Figure 23D shows a cross section "AA" of the light structure shown in Figure 23C. The light structure includes a 5-light tube 2306 and an internal shaft 2308. In other embodiments, other structures may be used for light tubes 2306 (for example, double light tubes in which the second light is used to inflate and deflate the balloon). The positioning system 2300 may also include an access mechanism 2310 to inflate / deflate the balloon, which may allow the connection of a syringe or inflation device to inflate / deflate a balloon. Alternatively or additionally, a tube with an attached stopcock can be connected to the access mechanism 2310.

Figures 24A-24D show another example of a positioning system 2400 according to an embodiment of the present invention. In the positioning system 2400, the proximal outer shaft 2402 may have a larger diameter compared to the diameter of the proximal outer shaft 2220 (Figure 22). The larger diameter can reduce bleeding when the placement system is used without an introducer. Alternatively, when an introducer is used, the largest diameter may correspond to the inner diameter of the introducer which, in turn, may depend on the outer diameter of the outer shell. Having no gap between the introducer and the placement system can reduce the risk of a potential recovery problem of the placement system through the

E11153142

20-08-2014

introducer due to trapped blood. Consequently, the positioning system 2400 may include a floating tube 2404 that fills the gap between the internal and external assemblies, thereby reducing the risk of the internal assembly deforming under compression, which would result in forces of greater friction within the placement system during the new stent capture. The positioning system 2400 may be substantially similar to the placement system 2200 in all other aspects (for example, the closed position, figures 24A and 24B; the open position, figure 24C).

Figures 25A-C show another example of a placement system 2500 according to an embodiment of the present invention.

The placement system 2500 may include one or more distal balls 2536 with respect to the stent valve. That the balloon (s) are distal to the stent valve avoids having to introduce the positioning system deeper into the body (for example, in the ascending aorta) to carry out the dilation, thereby reducing the risk of injury to the the body and improving the manipulation of the device (for example, the rigid device is not bent over the aortic arch). The balloon (s) 2536 may be used, for example, for valvuloplasty before implantation of the stent valve and / or after dilation of the implanted stent valve to improve stent anchoring. Figures 25B and 25C show the ball (s) 2536 in the closed and open positions, respectively.

The first set of the placement system 2500 may include a tip 2502, an inner ball shaft 2504, an outer cover 2506, and a floating tube 2508. The second set may include an internal (distal) shaft 2510, a stent carrier 2512 transition, a stent carrier 2514, a sleeve 2516, a transition shaft connector 2518 of decreasing section, and an outer (proximal) shaft 2520 . The handle assembly may include a clamp handle connector 2522, a clamp handle cavity 2524, an O-ring 2526, a metal shaft 2528, and a thrust handle 2530. The balloon assembly may include an outer shaft 2532, an inner shaft 2534, a balloon 2536 and a Y connector 2538.

Figures 26A-C show another example of a positioning system 2600 according to an embodiment of the present invention. The positioning system 2600 may include an integrated introducer 2602, which may be an additional assembly that houses the second assembly. The outer cover of the positioning system is shown as 2604. The introducer 2602 may include a connection line 2606, a stopcock 2608 and a housing 2610 for the sealing membrane 2612. The stopcock 2608 can serve as an access point, for example, for a syringe that contains fluid (for example, saline solution). The connection line 2606 can be used to transport the fluid from the syringe to the light of the introducer, and the sealing membrane 2612 can seal the introducer against the outside environment. After implantation of the stent valve, the components of the positioning system 2600 (for example, the first set and the second set) other than the introducer 2602 can be recovered through the introducer. Then, through the introducer 2602, another medical device such as, for example, a closing device can be introduced. Examples of closure devices are described below in connection with Figures 29A-33B. As another example, an intravascular ultrasound (IVUS) ultrasound device (IVUS) can be introduced through the introducer 2602. The placement system 2600 can be substantially similar to the placement system 2200 in all other aspects.

Figure 27 is a flow diagram 2700 of illustrative steps involved in the replacement of a defective valve (eg, native or artificial). Figures 28A-28C illustrate (without limitation) various steps referred to in the flow chart of Figure 27. In step 2702, a stent valve (for example, a single stent valve or a valve double stent) can be removably attached to a placement system. For example, one or more joining elements of a stent component (for example, joining elements 808, figure 8B) can be fixed to a stent holder of the positioning device (for example, stent holder 2222, figure 22) . A collapsible element (for example, the outer cover 2206, figure 22) can be placed on the stent joint / carrier elements to keep the stent valve in a folded configuration and attached to the positioning system.

In step 2704, the stent valve can be placed at an implantation site in a folded configuration. For example, Figure 28A ("introduction" and "placement") shows that the stent valve 2802, while still attached to the positioning system by means of the stent holder 2804 and contained completely inside the outer shell 2806, can be inserted into the body of a patient along the guide wire 2808, so that the tip 2810 of the positioning system passes through the defective valve 2812. The positioning system can be manipulated forward and / or backward, for example, until it is considered that the stent valve is positioned correctly.

In step 2706, the stent valve can be partially expanded, for example, to determine (step 2708) if the stent valve is in fact correctly positioned and / or to check (step 2710) if the stent valve is functioning in proper way. For example, Fig. 28A ("partial release") shows that the outer cover 2806 can be partially removed from the proximal section 2814 of the stent valve, while the stent valve joint members 2816 remain limited by the

55 E11153142

20-08-2014

outer cover 2806 on the stent holder 2804.

In step 2712, when the stent valve is correctly positioned at the implantation site and / or the stent valve works properly, the stent valve can be separated from the positioning system to cause the stent valve to expand to its configuration fully expanded. For example, Figure 28C ("final release") shows that, with the removal of the connecting elements 2816 and the stent holder 2804 from the inside of the outer cover 2806, the connecting elements 2816 of the stent valve 2802 can automatically separating from the stent holder 2804 (or in response to inflation of the balloon in other embodiments), thereby causing the stent valve to expand to its fully expanded configuration. Then, the second set of the positioning device can be reattached with the first set / outer cover and removed from the patient's body. For example, Figure 28C ("recovery of the positioning device") shows that the second set 2818 can be passed through the replacement stent valve 2802 toward the distal end of the stent valve. Then, the second set 2818 and the first set / outer cover 2806 that have been reattached can be passed through the stent valve 2802 again in the proximal direction before exiting the patient's body.

When the stent valve is not positioned correctly (step 2708), in step 2714 the stent valve can be returned to the folded configuration and placed back into the patient's body. An illustration of this scenario is illustrated in Figure 28B ("new stent capture / repositioning"), in which the outer cover 2806 slides in the proximal direction over the proximal section 2814 of the stent valve to re-capture The stent valve. Then, the stent valve can be repositioned and released, so that the stent valve fastener 2820 receives a ring 2822 from the defective valve. Similarly, when the stent valve fails in response to a check (step 2710), in step 2716 the stent valve can be returned to the folded configuration and can be removed from the patient's body.

Figures 29A-33B show illustrative embodiments of closure devices (occluders) compatible with guidewires for sealing access holes and associated surgical instruments according to some embodiments of the present invention. An occluder of this type can repair, for example, a cardiac access opening (eg, a ventricular opening) used for valve replacement. The occluder can be inserted into the body of a patient after a replacement valve is implanted (or removed due to malfunction or a complication during installation). The embodiments of the present invention address deficiencies with conventional closure devices, such as the clearance of their adjustment. Conventional closing devices also lack a central light, which makes them incompatible with guide wire placement systems.

Figures 29A and 29B are side and perspective views of an occluder 2900. The occluder 2900 may include stainless steel wire, nitinol, textile fibers, threads, biocompatible materials and / or other suitable materials that allow the device to function as it is. want. In some embodiments, at least a portion of the occluder 2900 may be provided / filled with a flexible material but allowing a tight fit such as, for example, a membrane or foam. The occluder 2900 may or may not include a skeleton (for example, reticular structure with a filler material) and / or sealing membranes. Such a skeleton may comprise nitinol, stainless steel, magnesium, nylon, polyester, polypropylene, polydioxanone, other suitable material (s), or a combination thereof. The filler material may include, for example, polyester, polyurethane, gelatin, other suitable material (s), or a combination thereof. When the occluder 2900 includes a sealing mechanism, such a mechanism may be flexible so as not to interfere with the expansion or folding of the occluder 2900 (described below) according to some embodiments of the present invention.

The upper part 2902 of the occluder 2900 can be placed on the luminal side of an access hole, while the lower part 2904 can be placed outside the access hole. The compatibility of the guide wire can be achieved through a central channel inside the occluder 2900. The central channel may include at its lower end, for example, a hollow screw device 2906 for attaching the occluder 2900 to a catheter during placement and separation of the occluder from the catheter after installation inside the access hole. In other embodiments, occluder 2900 can be attached to / separated from a catheter by a thin wall that can be twisted, by a hook-shaped connection mechanism, or by a mechanism that is separated by galvanic corrosion or the like.

The occluder 2900 may include a channel sealing mechanism 2908 such as, for example, a foam and / or self-sealing membrane. In some embodiments, the channel sealing mechanism 2908 may include a valve (for example, one or more plastic leaflets). The channel sealing mechanism 2908 can prevent blood flow through the occluder from the upper / luminal part 2902 to the lower part 2904 once the occluder is installed inside the access hole. During placement, a guidewire that is placed through the channel seal 2908 (and the central channel) can substantially or completely prevent blood flow through the channel closure mechanism 2908. In some embodiments, mechanism 2908 may be based, at least in part, on blood coagulation to form a plug. The 2908 mechanism (including a membrane, an iris mechanism, or folding walls) can form the seal (with or without the help of blood clotting).

E11153142

20-08-2014

The upper / luminal part 2902 of the occluder 2900 may be made of different material (s) (or of the same material (s) but having different characteristics) than the material (s) used ( s) for the lower / outer part 2904. For example, the lower / outer part 2904 may be made of a thicker or more porous material than the upper / luminous part 2902 to facilitate the formation of scar tissue on the outside. Bioabsorbable material (s) can also be used for part 2902 and / or 2904 of occluder 2900 (for example, magnesium and / or polydioxanone for a skeleton part and / or polydioxanone, polyhydroxybutyrate and / or gelatin as filling).

Figure 30 shows a perspective view of a guide wire 3000 to guide the placement of occluder 2900 to the access hole. The guide wire 3000 may be the same guide wire used, for example, for a valve replacement surgery involving one of the positioning systems shown in Figures 22A-26C. Figure 31 shows a perspective view of a threaded catheter 3100 for joining the occluder 2900 during placement and separation of the occluder 2900 once the occluder installation is completed. As shown in Figures 32A and 32B, the screw device 2906 of the occluder 2900 can be attached to the threaded catheter 3100, and the occluder 2900 can be loaded into the second catheter 3202. For example, the second catheter 3202 may be part of the positioning system (eg, figures 26A-C) used to place a replacement valve. The guide wire 3000 can extend through both the central channel of the occluder 2900 and the second catheter 3200. The guide wire 3000 can also be removable and reinsertable. Figure 32B shows that the occluder can be partially discharged by moving the 3100 with respect to catheter 3202. Advantageously, if occluder 2900 is not positioned correctly after partial release, it can be reloaded into catheter 3202 and relocated to the appropriate location within the access hole without excessive manipulation of occluder 2900 and / or associated placement instruments .

Figures 33A and 33B illustrate perspective and side views of occluder 2900 in an expanded configuration within an access hole according to an embodiment of the present invention. Preferably, the luminal / upper portion 2902 and the outer / lower portion 2904 of the occluder 2900 cover the access hole completely. The central channel is also preferably sealed, for example, by a sealing foam 2908 and / or self-sealing membrane.

Therefore, it is noted that stent valves (for example, single stent valves and double stent valves) and associated methods and systems for surgery are provided. Although particular embodiments have been disclosed herein in detail, this has been done by way of example only for illustrative purposes, and is not intended to be limiting with respect to the scope of the following claims that follow. In particular, the inventors contemplate that various substitutions, alterations and modifications can be carried out without departing from the spirit and scope of the invention as defined in the claims. Other aspects, advantages, and modifications are considered to be within the scope of the following claims. The claims presented are representative of the inventions disclosed herein.

119 members in 18 offices

This recordMember, by publication datePriority claim8 more offices are in the list below

Priority claims4

Priority claims
Document	Office	Kind	Date
753071P	United States of America	–	2005-12-22
75307105	United States of America	P	2005-12-22
755590P	United States of America	–	2005-12-29
75559005	United States of America	P	2005-12-29

Members119

Family members, oldest first
Document	Office	Kind
AU2006328896A1	Australia	A1	2007-06-28
CA2634358A1	Canada	A1	2007-06-28
WO2007071436A2	World Intellectual Property Organization (WIPO)	A2	2007-06-28
US2007213813A1	United States of America	A1	2007-09-13
WO2007071436A3	World Intellectual Property Organization (WIPO)	A3	2007-11-15
WO2007071436B1	World Intellectual Property Organization (WIPO)	B1	2008-01-17
AU2007294199A1	Australia	A1	2008-03-13
CA2657839A1	Canada	A1	2008-03-13
CA2659690A1	Canada	A1	2008-03-13
CA2755263A1	Canada	A1	2008-03-13
WO2008028569A1	World Intellectual Property Organization (WIPO)	A1	2008-03-13
MX2008008068A	Mexico	A	2008-09-10
EP1968491A2	European Patent Office (EPO)	A2	2008-09-17
KR20080103510A	Republic of Korea	A	2008-11-27
DE202007018551U1	Germany	U1	2008-12-11
CN101374477A	China	A	2009-02-25
AU2009200985A1	Australia	A1	2009-04-02
MX2009002556A	Mexico	A	2009-05-13
EP2059192A1	European Patent Office (EPO)	A1	2009-05-20
JP2009520535A	Japan	A	2009-05-28
EP2074964A1	European Patent Office (EPO)	A1	2009-07-01
US2009171432A1	United States of America	A1	2009-07-02
US2009171447A1	United States of America	A1	2009-07-02
KR20090078327A	Republic of Korea	A	2009-07-17
KR20090082181A	Republic of Korea	A	2009-07-29
JP2009195712A	Japan	A	2009-09-03
CN101623217A	China	A	2010-01-13
CN101636128A	China	A	2010-01-27
JP2010502320A	Japan	A	2010-01-28
EP1968491B1	European Patent Office (EPO)	B1	2010-07-07
ATE472985T1	Austria	T1	2010-07-15
DE602006015356D1	Germany	D1	2010-08-19
EP2248486A2	European Patent Office (EPO)	A2	2010-11-10
AU2007294199B2	Australia	B2	2010-11-18
EP2248486A3	European Patent Office (EPO)	A3	2011-03-09
AU2011200683A1	Australia	A1	2011-03-10
BRPI0716544A2	Brazil	A2	2011-05-03
EP2316381A2	European Patent Office (EPO)	A2	2011-05-04
AU2011200683B2	Australia	B2	2011-05-12
EP2059192B1	European Patent Office (EPO)	B1	2011-07-27
KR20110089190A	Republic of Korea	A	2011-08-04
ATE517589T1	Austria	T1	2011-08-15
BRPI0722366A2	Brazil	A2	2011-08-16
EP2316381A3	European Patent Office (EPO)	A3	2011-08-31
DK2059192T3	Denmark	T3	2011-09-19
EP2368527A1	European Patent Office (EPO)	A1	2011-09-28
PT2059192E	Portugal	E	2011-10-17
BRPI0620302A2	Brazil	A2	2011-11-08
ES2368459T3	Spain	T3	2011-11-17
EP2387973A1	European Patent Office (EPO)	A1	2011-11-23
SI2059192T1	Slovenia	T1	2011-11-30
AU2009200985B2	Australia	B2	2011-12-08
AU2011253586A1	Australia	A1	2011-12-15
JP2011255195A	Japan	A	2011-12-22
PL2059192T3	Poland	T3	2011-12-30
CA2657839C	Canada	C	2012-01-03
EP2420207A2	European Patent Office (EPO)	A2	2012-02-22
EP2422749A2	European Patent Office (EPO)	A2	2012-02-29
EP2422750A2	European Patent Office (EPO)	A2	2012-02-29
EP2074964B1	European Patent Office (EPO)	B1	2012-03-07
ATE547997T1	Austria	T1	2012-03-15
EP2420207A3	European Patent Office (EPO)	A3	2012-03-28
EP2422749A3	European Patent Office (EPO)	A3	2012-03-28
KR101146035B1	Republic of Korea	B1	2012-05-21
ES2381810T3	Spain	T3	2012-05-31
EP2422750A3	European Patent Office (EPO)	A3	2012-06-13
CN101374477B	China	B	2012-07-04
KR101139186B1	Republic of Korea	B1	2012-07-05
JP4989675B2	Japan	B2	2012-08-01
US2012197386A1	United States of America	A1	2012-08-02
CN101636128B	China	B	2012-08-15
JP2012152563A	Japan	A	2012-08-16
JP5031838B2	Japan	B2	2012-09-26
KR20120124498A	Republic of Korea	A	2012-11-13
CN102772273A	China	A	2012-11-14
KR101258016B1	Republic of Korea	B1	2013-04-30
CN101623217B	China	B	2013-08-21
AU2006328896B2	Australia	B2	2013-08-29
CA2755263C	Canada	C	2014-01-21
AU2011253586B2	Australia	B2	2014-04-03
JP5465702B2	Japan	B2	2014-04-09
KR101388813B1	Republic of Korea	B1	2014-04-23
EP2316381B1	European Patent Office (EPO)	B1	2014-05-21
CA2659690C	Canada	C	2014-08-05
JP5581349B2	Japan	B2	2014-08-27
ES2494618T3This record	Spain	T3	2014-09-15
EP2422749B1	European Patent Office (EPO)	B1	2014-09-24
EP2420207B1	European Patent Office (EPO)	B1	2014-12-03
EP2422750B1	European Patent Office (EPO)	B1	2014-12-03
ES2526563T3	Spain	T3	2015-01-13
US2015018938A1	United States of America	A1	2015-01-15
ES2528742T3	Spain	T3	2015-02-12
ES2529340T3	Spain	T3	2015-02-19
US2015094801A1	United States of America	A1	2015-04-02
CY1111861T1	Cyprus	T1	2015-11-04
US9216082B2	United States of America	B2	2015-12-22
CN102772273B	China	B	2016-03-30
US2016100944A1	United States of America	A1	2016-04-14
US2017189178A1	United States of America	A1	2017-07-06
US2017290661A1	United States of America	A1	2017-10-12

Showing 100 of 119

Cardiac valve prosthesis

Abstract

Term

E11153142

DESCRIPTION

60 E11153142

E11153142

E11153142

60 E11153142

55 E11153142

60 E11153142

60 E11153142

55 E11153142

E11153142

55 E11153142

60 E11153142

60 E11153142

E11153142

55 E11153142

E11153142

Priority claims4

Members119

Numbers

Titles2

Classification